dapsone has been researched along with Allergy, Drug in 96 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine." | 8.12 | Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. ( Budiawan, T; Ferdiana, A; Imaniar, C; Irwanto, A; Krismawati, H; Mieras, L; Pongtiku, A; Singh, P; Wahyuni, T, 2022) |
| "To investigate the molecular mechanisms for HLA-B*13:01 in the pathogenesis of Dapsone-induced drug hypersensitivity (DDS-DIHS), we performed crystallization and expanded drug-specific CTLs to analyze the pathological role of DDS-DIHS." | 8.12 | Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity. ( Cao, Y; Chung, WH; Dai, Y; Jiang, H; Lee, YS; Ouyang, S; Wang, CW; Wang, H; Wang, Z; Zhu, Y, 2022) |
| "In the Netherlands dapsone is used for the treatment of dermatitis herpetiformis, leprosy and Pneumocystis jiroveci pneumonia and prophylaxis in case of cotrimoxazole allergy." | 7.83 | A lethal case of the dapsone hypersensitivity syndrome involving the myocardium. ( Beuers, U; de Boer, HH; de Vries, HJ; Hoogeveen, RM; Nellen, FJ; Thurlings, RM; van der Bom, T; van der Wal, AC; van Lent, AU; Wind, BS, 2016) |
| "To Study the incidence and clinical characteristics of dapsone hypersensitivity syndrome (DHS) among MDT-treated leprosy patients from 2006 to 2009 in China." | 7.78 | Dapsone hypersensitivity syndrome among leprosy patients in China. ( Shen, J; Tian, W; Yan, L; Zhang, G; Zhou, M, 2012) |
| "Dapsone syndrome is a potentially fatal hypersensitivity reaction to sulphone." | 7.78 | Dapsone syndrome--first Malaysian paediatric case report. ( Elizawaty, O; Norlijah, O; Thevarajah, S; Zurina, Z, 2012) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy." | 7.74 | Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. ( Hawksworth, RA; Lewis, J; Pandey, B; Shrestha, K; Walker, SL, 2007) |
| "In summary, we report a case of dapsone hypersensitivity syndrome with classical symptoms of fever, rash and multi-organ involvement including a rare manifestation of myocarditis." | 7.73 | Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. ( Ng, V; Oh, DC; Tan, CH; Tay, YK; Teo, RY, 2006) |
| "Dapsone syndrome is a rare hypersensitivity reaction to dapsone and is characterized by high fever, papular or exfoliative dermatitis, progressing to liver toxicity and generalized lymphadenopathy, resembling a mononucleosis infection." | 7.73 | Dapsone syndrome with acute renal failure during leprosy treatment: case report. ( Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A, 2005) |
| "Dapsone can rarely cause a hypersensitivity reaction called dapsone syndrome, consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 7.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "We report 3 cases of dapsone hypersensitivity syndrome due to anti-malarial chemoprophylactic treatment with maloprim, in military servicemen, presenting like a viral exanthem." | 7.72 | Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review. ( Khoo, BP; Oh, HM; Poh, WT; Tee, AK; Wee, IY, 2004) |
| "Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis." | 7.72 | A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003) |
| "There has been an increase in the reports of dapsone hypersensitivity syndrome (DHS) in the past few years, coinciding with the introduction of multidrug therapy (MDT) for leprosy world-wide." | 7.71 | Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. ( Lakshmi, TS; Rao, PN, 2001) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 7.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "In order to address the question whether hypersensitivity reactions to dapsone are becoming more frequent, the clinical data of 7300 leprosy patients treated between 1949 and September 1988 at the McKean Rehabilitation Centre in Thailand were reviewed." | 7.67 | Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy. ( Richardus, JH; Smith, TC, 1989) |
| "Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation." | 5.56 | Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. ( Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F, 2020) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 5.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| "A 45-year-old woman developed hypersensitivity to dapsone when this drug was used to treat corticoid-dependent asthma." | 4.79 | [Hypersensitivity syndrome caused by dapsone. Transient circulating clone T]. ( Bocquet, H; Bourgault-Villada, I; Delfau-Larue, MH; Revuz, J; Roujeau, JC; Wechsler, J, 1995) |
| "The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine." | 4.12 | Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. ( Budiawan, T; Ferdiana, A; Imaniar, C; Irwanto, A; Krismawati, H; Mieras, L; Pongtiku, A; Singh, P; Wahyuni, T, 2022) |
| "To investigate the molecular mechanisms for HLA-B*13:01 in the pathogenesis of Dapsone-induced drug hypersensitivity (DDS-DIHS), we performed crystallization and expanded drug-specific CTLs to analyze the pathological role of DDS-DIHS." | 4.12 | Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity. ( Cao, Y; Chung, WH; Dai, Y; Jiang, H; Lee, YS; Ouyang, S; Wang, CW; Wang, H; Wang, Z; Zhu, Y, 2022) |
| "In the Netherlands dapsone is used for the treatment of dermatitis herpetiformis, leprosy and Pneumocystis jiroveci pneumonia and prophylaxis in case of cotrimoxazole allergy." | 3.83 | A lethal case of the dapsone hypersensitivity syndrome involving the myocardium. ( Beuers, U; de Boer, HH; de Vries, HJ; Hoogeveen, RM; Nellen, FJ; Thurlings, RM; van der Bom, T; van der Wal, AC; van Lent, AU; Wind, BS, 2016) |
| "Dapsone hypersensitivity syndrome (DHS) can be classified as a 'drug reaction with eosinophilia and systemic symptoms' (DRESS)." | 3.81 | Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report. ( Chellini, PR; Gavilanes, MC; Nery, JA; Palacio, AL; Rego, JG, 2015) |
| "We performed a genomewide association study involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), using log-additive tests of single-nucleotide polymorphisms (SNPs) and imputed HLA molecules." | 3.79 | HLA-B*13:01 and the dapsone hypersensitivity syndrome. ( Bao, FF; Bei, JX; Chen, MF; Chen, SL; Chen, SM; Chen, XC; Chu, TS; de Bakker, PI; Foo, JN; Fu, XA; Huang, JX; Huang, ZM; Irwanto, A; Jia, XM; Li, JH; Li, JL; Li, M; Li, Y; Li, Z; Liany, H; Liu, DC; Liu, H; Liu, HX; Liu, J; Liu, JJ; Liu, YX; Liu, ZS; Long, H; Low, HQ; Lu, XM; Ma, SS; Ning, Y; Niu, GY; Pulit, SL; Shen, JP; Shi, BQ; Sun, YH; Tian, HQ; Wang, C; Wang, H; Wang, JQ; Wang, LM; Wang, N; Wang, XD; Wang, ZZ; Wei, ZH; Wu, WB; Xiao, P; Xiong, L; Yan, LB; Yang, J; Yang, Q; Yang, RD; You, JB; Yu, DB; Yu, GQ; Yu, XL; Yu, YX; Zeng, YX; Zhang, FR; Zhang, GC; Zhang, LH; Zhang, ZX; Zheng, ZY; Zhou, GZ; Zhou, Y, 2013) |
| "Dapsone syndrome is a potentially fatal hypersensitivity reaction to sulphone." | 3.78 | Dapsone syndrome--first Malaysian paediatric case report. ( Elizawaty, O; Norlijah, O; Thevarajah, S; Zurina, Z, 2012) |
| "To Study the incidence and clinical characteristics of dapsone hypersensitivity syndrome (DHS) among MDT-treated leprosy patients from 2006 to 2009 in China." | 3.78 | Dapsone hypersensitivity syndrome among leprosy patients in China. ( Shen, J; Tian, W; Yan, L; Zhang, G; Zhou, M, 2012) |
| " The second month of MDT was the riskiest for newly treated patients; approximately 20% of patients succumbed to liver failure, 33% to dapsone (diaminodiphenylsulfone/DDS) allergy, and 27% to renal insufficiency during this period." | 3.77 | Causes of death among active leprosy patients in China. ( Li, W; Liu, M; Shen, J; Zhou, M, 2011) |
| "Topical dapsone gel 5% is indicated for the treatment of acne vulgaris and has been marketed since late 2008." | 3.76 | Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients? ( Webster, GF, 2010) |
| "Dapsone hypersensitivity syndrome (DHS) is a potentially life-threatening adverse drug reaction consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.75 | Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. ( Chu, CY; Sheen, YS; Tsai, TF; Wang, SH, 2009) |
| "Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy." | 3.74 | Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. ( Hawksworth, RA; Lewis, J; Pandey, B; Shrestha, K; Walker, SL, 2007) |
| "Dapsone syndrome is a rare hypersensitivity reaction to dapsone and is characterized by high fever, papular or exfoliative dermatitis, progressing to liver toxicity and generalized lymphadenopathy, resembling a mononucleosis infection." | 3.73 | Dapsone syndrome with acute renal failure during leprosy treatment: case report. ( Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A, 2005) |
| "In summary, we report a case of dapsone hypersensitivity syndrome with classical symptoms of fever, rash and multi-organ involvement including a rare manifestation of myocarditis." | 3.73 | Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. ( Ng, V; Oh, DC; Tan, CH; Tay, YK; Teo, RY, 2006) |
| "We report 3 cases of dapsone hypersensitivity syndrome due to anti-malarial chemoprophylactic treatment with maloprim, in military servicemen, presenting like a viral exanthem." | 3.72 | Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review. ( Khoo, BP; Oh, HM; Poh, WT; Tee, AK; Wee, IY, 2004) |
| "Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis." | 3.72 | A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003) |
| "Dapsone can rarely cause a hypersensitivity reaction called dapsone syndrome, consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia." | 3.72 | Dapsone induced cholangitis as a part of dapsone syndrome: a case report. ( Choudhuri, G; Dhingra, S; Itha, S; Kumar, A, 2003) |
| "There has been an increase in the reports of dapsone hypersensitivity syndrome (DHS) in the past few years, coinciding with the introduction of multidrug therapy (MDT) for leprosy world-wide." | 3.71 | Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. ( Lakshmi, TS; Rao, PN, 2001) |
| "A male patient who was being treated with oral prednisone for erosive mucocutaneous pemphigus lesions developed fever, jaundice, a rash, and anemia within 2 wk of starting dapsone therapy." | 3.69 | Sulfone syndrome in a patient receiving steroids for pemphigus. ( Barnard, GF; Dagher, RK; Scharf, MJ, 1994) |
| "A 34-year-old woman with HIV infection and no other opportunistic infections presented a classic sulfone syndrome, manifested by fever, rash, hemolytic anemia, and fulminant hepatitis due to dapsone hypersensitive reaction, with a fatal outcome." | 3.69 | Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. ( Baffoe-Bonnie, H; Chalasani, P; Jurado, RL, 1994) |
| "In order to address the question whether hypersensitivity reactions to dapsone are becoming more frequent, the clinical data of 7300 leprosy patients treated between 1949 and September 1988 at the McKean Rehabilitation Centre in Thailand were reviewed." | 3.67 | Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy. ( Richardus, JH; Smith, TC, 1989) |
| "A patient being treated with dapsone developed a hypersensitivity reaction with typical features of the "sulfone syndrome," including fever, malalse, and hepatitis." | 3.67 | Liver involvement in the sulfone syndrome. ( Cattau, EL; Johnson, DA; Kuritsky, JN; Zimmerman, HJ, 1986) |
| "The differential incidence of adverse drug reactions (ADR) between trimethoprim-sulfamethoxazole and dapsone might be explained, in part, by differences in the inherent toxicity of the hydroxylamine metabolites of sulfamethoxazole and dapsone." | 2.69 | Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. ( Bellevue, FH; Reilly, TP; Svensson, CK; Woster, PM, 1998) |
| "Dapsone has potent anti-inflammatory effects and remains an effective therapy in a variety of skin disorders: cutaneous vasculitis, neutrophilic dermatoses and blistering disorders." | 2.48 | Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. ( Ezzedine, K; Guillet, S; Milpied, B; Seneschal, J; Taïeb, A, 2012) |
| "Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation." | 1.56 | Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. ( Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F, 2020) |
| "Dapsone is a sulfone derived drug used in the treatment of leprosy and several chronic inflammatory dermatological diseases." | 1.51 | Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report. ( George, NE; Priya, S; Shukkoor, AA; Thangavelu, S, 2019) |
| "Dapsone is a sulfone-type drug used widely for different infectious, immune, and hypersensitivity disorders as an antibacterial treatment alone or in combination for leprosy and sometimes for infected skin lesions." | 1.40 | Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: a case report. ( Choi, YR; Garcia, A; Hong, G; Kang, EK; Kang, HJ; Kim, JG; Lee, JM; Lee, KB; Lee, KW; Park, JD; Suh, KS; Suh, SW; Yi, NJ; You, T, 2014) |
| "Dapsone has several adverse effects in its profile that make it a potentially dangerous second-line agent." | 1.33 | Adverse reactions associated with dapsone therapy in HIV-positive patients: a case presentation and review. ( Miller, JA; Reust, R; Stephens, JR; Stroup, JS, 2006) |
| "Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy." | 1.33 | The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. ( Abidi, MH; Ibrahim, RB; Kozlowski, JR; Peres, E, 2006) |
| "Dapsone therapy was then stopped or decreased." | 1.32 | [Dapsone-induced sensory peripheral neuropathy]. ( Dega, H; Dubertret, L; Méry, L; Prost, C, 2003) |
| "Dapsone was the most commonly used drug (51 patients), followed by methotrexate (24 patients), azathioprine (23 patients), and cyclophosphamide (15 patients); prednisone, always given as adjunctive treatment, was used in 17 patients." | 1.31 | The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. ( Ahmed, AR; Baltatzis, S; Foster, CS; Miserocchi, E; Roque, MR, 2002) |
| "The overall incidence of adverse events (AE) in our study cohort was 39%." | 1.29 | Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. ( Beumont, MG; Graziani, A; MacGregor, RR; Ubel, PA, 1996) |
| "A 59-year-old man with Duhring's disease (herpetiform dermatitis) developed undulating fever and pulmonary infiltrates soon after sulfapyridine treatment was started." | 1.28 | [Hypersensitivity pneumonia caused by sulfonamides]. ( Criée, CP; Hüttemann, U; von Breska, B, 1990) |
| "A leprosy patient who developed acute renal failure on multidrug therapy is reported." | 1.27 | Acute renal failure--a complication of new multidrug regimen for treatment of leprosy. ( Acharya, VM; Almeida, AF; Dedhia, NM; Khanna, UB; Mittal, BV, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (19.79) | 18.7374 |
| 1990's | 23 (23.96) | 18.2507 |
| 2000's | 23 (23.96) | 29.6817 |
| 2010's | 25 (26.04) | 24.3611 |
| 2020's | 6 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Krismawati, H | 2 |
| Ferdiana, A | 1 |
| Irwanto, A | 3 |
| Budiawan, T | 1 |
| Imaniar, C | 1 |
| Wahyuni, T | 2 |
| Singh, P | 1 |
| Mieras, L | 1 |
| Pongtiku, A | 2 |
| Jiang, H | 1 |
| Wang, CW | 1 |
| Wang, Z | 2 |
| Dai, Y | 1 |
| Zhu, Y | 1 |
| Lee, YS | 1 |
| Cao, Y | 1 |
| Chung, WH | 1 |
| Ouyang, S | 1 |
| Wang, H | 4 |
| Ali, SE | 1 |
| Meng, X | 2 |
| Kafu, L | 1 |
| Hammond, S | 1 |
| Zhao, Q | 3 |
| Ogese, M | 1 |
| Sison-Young, R | 1 |
| Jones, R | 1 |
| Chan, B | 1 |
| Livoti, L | 1 |
| Sun, Y | 5 |
| Sun, L | 3 |
| Liu, H | 7 |
| Topping, A | 1 |
| Goldring, C | 1 |
| Zhang, F | 6 |
| Naisbitt, DJ | 2 |
| Almutairi, M | 1 |
| Lister, A | 1 |
| Line, J | 1 |
| Adair, K | 1 |
| Tailor, A | 1 |
| Waddington, J | 1 |
| Clarke, E | 1 |
| Gardner, J | 1 |
| Thomson, P | 1 |
| Harper, N | 1 |
| Ostrov, DA | 1 |
| MacEwan, DJ | 1 |
| Pirmohamed, M | 2 |
| Naisbitt, D | 1 |
| Irwan, ID | 1 |
| Maladan, Y | 1 |
| Sitanggang, YA | 1 |
| Tanjung, R | 1 |
| Oktavian, A | 1 |
| Liu, J | 3 |
| Devarbhavi, H | 1 |
| Raj, S | 1 |
| Joseph, T | 1 |
| Singh, R | 1 |
| Patil, M | 1 |
| Schmidgen, MI | 1 |
| Butsch, F | 1 |
| Schadmand-Fischer, S | 1 |
| Steinbrink, K | 1 |
| Grabbe, S | 1 |
| Weidenthaler-Barth, B | 1 |
| Loquai, C | 1 |
| Yue, Z | 1 |
| Wang, C | 2 |
| Yu, W | 1 |
| Cao, J | 1 |
| Bao, F | 1 |
| Shukkoor, AA | 1 |
| Thangavelu, S | 1 |
| George, NE | 1 |
| Priya, S | 1 |
| Wonnaparhown, A | 1 |
| Chung, C | 1 |
| Shadix, S | 1 |
| Patel, R | 1 |
| Pandat, S | 1 |
| Chinchilla, D | 1 |
| Lindgren, B | 1 |
| Falk, J | 1 |
| Craig, J | 1 |
| MacRae, C | 1 |
| Melvin, RG | 1 |
| Boggild, AK | 1 |
| Yan, L | 2 |
| Zhang, G | 2 |
| Chen, X | 1 |
| Yang, J | 2 |
| Li, M | 2 |
| Shen, J | 3 |
| Yu, M | 1 |
| Huo, R | 1 |
| Wang, B | 2 |
| Tian, W | 1 |
| Zhou, M | 2 |
| Zhang, FR | 1 |
| Fu, XA | 1 |
| Li, Y | 1 |
| Yu, GQ | 1 |
| Yu, YX | 1 |
| Chen, MF | 1 |
| Low, HQ | 1 |
| Li, JH | 1 |
| Bao, FF | 1 |
| Foo, JN | 1 |
| Bei, JX | 1 |
| Jia, XM | 1 |
| Liany, H | 1 |
| Wang, N | 2 |
| Niu, GY | 1 |
| Wang, ZZ | 1 |
| Shi, BQ | 1 |
| Tian, HQ | 1 |
| Liu, HX | 1 |
| Ma, SS | 1 |
| Zhou, Y | 1 |
| You, JB | 1 |
| Yang, Q | 1 |
| Chu, TS | 1 |
| Liu, DC | 1 |
| Yu, XL | 1 |
| Sun, YH | 1 |
| Ning, Y | 1 |
| Wei, ZH | 1 |
| Chen, SL | 1 |
| Chen, XC | 1 |
| Zhang, ZX | 1 |
| Liu, YX | 1 |
| Pulit, SL | 1 |
| Wu, WB | 1 |
| Zheng, ZY | 1 |
| Yang, RD | 1 |
| Long, H | 1 |
| Liu, ZS | 1 |
| Wang, JQ | 1 |
| Zhang, LH | 1 |
| Wang, LM | 1 |
| Xiao, P | 1 |
| Li, JL | 1 |
| Huang, ZM | 1 |
| Huang, JX | 1 |
| Li, Z | 1 |
| Xiong, L | 1 |
| Wang, XD | 1 |
| Yu, DB | 1 |
| Lu, XM | 1 |
| Zhou, GZ | 1 |
| Yan, LB | 1 |
| Shen, JP | 1 |
| Zhang, GC | 1 |
| Zeng, YX | 1 |
| de Bakker, PI | 1 |
| Chen, SM | 1 |
| Liu, JJ | 1 |
| Garcia, A | 1 |
| Yi, NJ | 1 |
| Lee, KB | 1 |
| Lee, JM | 1 |
| Choi, YR | 1 |
| Suh, SW | 1 |
| You, T | 1 |
| Lee, KW | 1 |
| Park, JD | 1 |
| Kang, HJ | 1 |
| Kim, JG | 1 |
| Kang, EK | 1 |
| Hong, G | 1 |
| Suh, KS | 1 |
| Pereira, CM | 1 |
| Vaz, M | 1 |
| Kotha, S | 1 |
| Santosh, NH | 1 |
| Sauvetre, G | 1 |
| MahÉvas, M | 1 |
| Limal, N | 1 |
| Guillaud, C | 1 |
| Khellaf, M | 1 |
| Bierling, P | 1 |
| Languille, L | 1 |
| Delbos, F | 1 |
| Noizat-Pirenne, F | 1 |
| Michel, M | 1 |
| Godeau, B | 1 |
| Gavilanes, MC | 1 |
| Palacio, AL | 1 |
| Chellini, PR | 1 |
| Nery, JA | 1 |
| Rego, JG | 1 |
| Hoogeveen, RM | 1 |
| van der Bom, T | 1 |
| de Boer, HH | 1 |
| Thurlings, RM | 1 |
| Wind, BS | 1 |
| de Vries, HJ | 1 |
| van Lent, AU | 1 |
| Beuers, U | 1 |
| van der Wal, AC | 1 |
| Nellen, FJ | 1 |
| Liu, Z | 1 |
| Chen, G | 1 |
| Kang, X | 1 |
| Han, M | 1 |
| Chen, R | 1 |
| Chen, C | 1 |
| Ly, KH | 1 |
| Dalmay, F | 1 |
| Gondran, G | 1 |
| Palat, S | 1 |
| Bezanahary, H | 1 |
| Cypierre, A | 1 |
| Fauchais, AL | 1 |
| Liozon, E | 1 |
| Parimi, L | 1 |
| Manifold, R | 1 |
| Marshman, G | 1 |
| Zhu, KJ | 1 |
| He, FT | 1 |
| Jin, N | 1 |
| Lou, JX | 1 |
| Cheng, H | 1 |
| Sheen, YS | 1 |
| Chu, CY | 1 |
| Wang, SH | 1 |
| Tsai, TF | 1 |
| do Valle, SO | 1 |
| França, AT | 1 |
| Pires, GV | 1 |
| Guimarães, P | 1 |
| Dias, GA | 1 |
| Levy, SA | 1 |
| Webster, GF | 1 |
| Liu, M | 1 |
| Li, W | 1 |
| Ceccarelli, L | 1 |
| Calisti, G | 1 |
| Delle Rose, D | 1 |
| Ricciardi, A | 1 |
| Maffongelli, G | 1 |
| Sordillo, P | 1 |
| Sarmati, L | 1 |
| Andreoni, M | 1 |
| Seneschal, J | 1 |
| Guillet, S | 1 |
| Ezzedine, K | 1 |
| Taïeb, A | 1 |
| Milpied, B | 1 |
| Piette, EW | 1 |
| Werth, VP | 1 |
| Zurina, Z | 1 |
| Elizawaty, O | 1 |
| Thevarajah, S | 1 |
| Norlijah, O | 1 |
| Méry, L | 1 |
| Dega, H | 1 |
| Prost, C | 1 |
| Dubertret, L | 1 |
| Itha, S | 1 |
| Kumar, A | 1 |
| Dhingra, S | 1 |
| Choudhuri, G | 1 |
| Leslie, KS | 1 |
| Gaffney, K | 1 |
| Ross, CN | 1 |
| Ridley, S | 1 |
| Barker, TH | 1 |
| Garioch, JJ | 1 |
| SMYLY, HJ | 1 |
| BROWNE, SG | 2 |
| Endres, HG | 1 |
| Tee, AK | 1 |
| Oh, HM | 1 |
| Wee, IY | 1 |
| Khoo, BP | 1 |
| Poh, WT | 1 |
| Ramam, M | 1 |
| Srivastava, P | 1 |
| Alves-Rodrigues, EN | 2 |
| Ribeiro, LC | 2 |
| Silva, MD | 2 |
| Takiuchi, A | 2 |
| Fontes, CJ | 2 |
| Rabel-Filho, OC | 1 |
| Martini-Filho, D | 1 |
| Takahashi, H | 1 |
| Tanaka, M | 1 |
| Tanikawa, A | 1 |
| Toyohara, A | 1 |
| Ogo, Y | 1 |
| Morimoto, A | 1 |
| Harato, R | 1 |
| Kobayashi, M | 1 |
| Amagai, M | 1 |
| Stroup, JS | 1 |
| Stephens, JR | 1 |
| Reust, R | 1 |
| Miller, JA | 1 |
| Abidi, MH | 1 |
| Kozlowski, JR | 1 |
| Ibrahim, RB | 1 |
| Peres, E | 1 |
| Sener, O | 1 |
| Doganci, L | 1 |
| Safali, M | 1 |
| Besirbellioglu, B | 1 |
| Bulucu, F | 1 |
| Pahsa, A | 1 |
| Teo, RY | 1 |
| Tay, YK | 1 |
| Tan, CH | 1 |
| Ng, V | 1 |
| Oh, DC | 1 |
| Pandey, B | 1 |
| Shrestha, K | 1 |
| Lewis, J | 1 |
| Hawksworth, RA | 1 |
| Walker, SL | 1 |
| Jopling, WH | 1 |
| Revuz, J | 2 |
| Hornac, P | 1 |
| Tomecki, KJ | 1 |
| Catalano, CJ | 1 |
| Mohamed, KN | 1 |
| Kromann, NP | 1 |
| Vilhelmsen, R | 1 |
| Stahl, D | 1 |
| Dhamija, R | 1 |
| Kumar, D | 1 |
| Khurana, G | 1 |
| Risse, L | 1 |
| Bernard, P | 1 |
| Brosset, A | 1 |
| Enginger, V | 1 |
| Bedane, C | 1 |
| Bonnetblanc, JM | 1 |
| Stephen, G | 1 |
| George, O | 1 |
| Mathai, D | 1 |
| Kaur, A | 1 |
| Abraham, OC | 1 |
| Puri, AS | 1 |
| Gupta, R | 1 |
| Ghoshal, UC | 1 |
| Khan, E | 1 |
| Aggarwal, R | 1 |
| Naik, SR | 1 |
| Barnard, GF | 1 |
| Scharf, MJ | 1 |
| Dagher, RK | 1 |
| Chalasani, P | 1 |
| Baffoe-Bonnie, H | 1 |
| Jurado, RL | 1 |
| Bocquet, H | 1 |
| Bourgault-Villada, I | 1 |
| Delfau-Larue, MH | 1 |
| Wechsler, J | 1 |
| Roujeau, JC | 1 |
| Korraa, H | 1 |
| Saadeh, C | 1 |
| Hortaleza, AR | 1 |
| Salta-Ramos, NG | 1 |
| Barcelona-Tan, J | 1 |
| Abad-Venida, L | 1 |
| Beumont, MG | 1 |
| Graziani, A | 1 |
| Ubel, PA | 1 |
| MacGregor, RR | 1 |
| Williams, D | 1 |
| Tingle, MD | 1 |
| Barry, M | 1 |
| Khoo, SH | 1 |
| O'Mahony, C | 1 |
| Wilkins, EG | 1 |
| Breckenridge, AM | 1 |
| Park, BK | 1 |
| Barber, BA | 1 |
| Pegram, PS | 1 |
| High, KP | 1 |
| McKenna, KE | 1 |
| Robinson, J | 1 |
| Reilly, TP | 2 |
| Bellevue, FH | 1 |
| Woster, PM | 2 |
| Svensson, CK | 2 |
| Mok, CC | 1 |
| Lau, CS | 1 |
| Wong, RW | 1 |
| Ng, PP | 1 |
| Goh, CL | 1 |
| Cook, DE | 1 |
| Kossey, JL | 1 |
| MacArthur, RD | 1 |
| Farrough, MJ | 1 |
| Crane, LR | 1 |
| Christiansen, J | 1 |
| Tegner, E | 1 |
| Irestedt, M | 1 |
| Rao, PN | 1 |
| Lakshmi, TS | 1 |
| Permal-Griffiths, S | 1 |
| Dhôte, R | 1 |
| Delègue, P | 1 |
| Vayre, L | 1 |
| Christoforov, B | 1 |
| Miserocchi, E | 1 |
| Baltatzis, S | 1 |
| Roque, MR | 1 |
| Ahmed, AR | 1 |
| Foster, CS | 1 |
| Thong, BY | 1 |
| Leong, KP | 1 |
| Chng, HH | 1 |
| Michaëlsson, G | 1 |
| Svensson, L | 1 |
| Lang, PG | 1 |
| Mohle-Boetani, J | 1 |
| Akula, SK | 1 |
| Holodniy, M | 1 |
| Katzenstein, D | 1 |
| Garcia, G | 1 |
| Pascual Velasco, F | 1 |
| de Soldenhoff, R | 1 |
| von Breska, B | 1 |
| Criée, CP | 1 |
| Hüttemann, U | 1 |
| Richardus, JH | 1 |
| Smith, TC | 1 |
| Smith, WC | 2 |
| Wille, RC | 1 |
| Morrow, JD | 1 |
| Jamrozik, K | 1 |
| Dedhia, NM | 1 |
| Almeida, AF | 1 |
| Khanna, UB | 1 |
| Mittal, BV | 1 |
| Acharya, VM | 1 |
| Johnson, DA | 1 |
| Cattau, EL | 1 |
| Kuritsky, JN | 1 |
| Zimmerman, HJ | 1 |
| Joseph, MS | 1 |
| Laing, AB | 1 |
10 reviews available for dapsone and Allergy, Drug
| Article | Year |
|---|---|
Features and Treatment of Dapsone-Induced Hepatitis, Based on Analysis of 44 Cases and Literature Review.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Female; Humans; Immunosuppressive Agen | 2017 |
A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing.
Topics: Adolescent; Adult; Aged; Alleles; Child; China; Dapsone; Drug Hypersensitivity; Drug Substitution; F | 2017 |
Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum.
Topics: Aged; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Female; Humans; Immune Tolerance; Immun | 2012 |
Dapsone in the management of autoimmune bullous diseases.
Topics: Agranulocytosis; Animals; Autoimmune Diseases; Dapsone; Disease Management; Drug Hypersensitivity; H | 2012 |
[Side effects of treatment with sulfones].
Topics: Adult; Agranulocytosis; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Eruptions; Drug | 1981 |
[Disulone hypersensitivity syndrome].
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Middl | 1994 |
[Hypersensitivity syndrome caused by dapsone. Transient circulating clone T].
Topics: Anti-Asthmatic Agents; Asthma; Blotting, Southern; Clone Cells; Dapsone; Drug Eruptions; Drug Hypers | 1995 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Ag | 1996 |
The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Hypersensitivity; Humans; Male; Opportunist | 1992 |
Are hypersensitivity reactions to dapsone becoming more frequent?
Topics: Adolescent; Adult; Child; Dapsone; Drug Hypersensitivity; Female; Humans; Male; Middle Aged | 1988 |
3 trials available for dapsone and Allergy, Drug
| Article | Year |
|---|---|
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
Topics: Antibodies, Monoclonal, Humanized; Complement C3; Dapsone; Dose-Response Relationship, Drug; Double- | 2017 |
Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
Topics: Cell Survival; Dapsone; Drug Hypersensitivity; Erythrocytes; Humans; Hydroxylamine; In Vitro Techniq | 1998 |
Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Topics: Adult; Anti-Infective Agents; Benzoxazoles; Biomarkers; Cell Separation; Cell Survival; Dapsone; Dru | 1999 |
83 other studies available for dapsone and Allergy, Drug
| Article | Year |
|---|---|
Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
Topics: Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Genetic Testing; Humans; Incidence; Indon | 2022 |
Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity.
Topics: Cicatrix; Dapsone; Drug Hypersensitivity; HLA-B Antigens; Humans; Receptors, Antigen, T-Cell; T-Lymp | 2022 |
Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System.
Topics: Coculture Techniques; Dapsone; Drug Hypersensitivity; Hepatocytes; Humans; Liver; Lymphocyte Activat | 2023 |
Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.
Topics: CD8-Positive T-Lymphocytes; Cysteine; Dapsone; Drug Hypersensitivity; Haptens; HLA-B Antigens; Human | 2023 |
Dapsone hypersensitivity syndrome.
Topics: Dapsone; Drug Hypersensitivity; Humans; Hypersensitivity; Syndrome | 2023 |
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Topics: Adolescent; Adult; Alleles; Biomarkers; Case-Control Studies; Clofazimine; Dapsone; Drug Hypersensit | 2020 |
Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Child; Dapsone; Drug Hypersensitivity; Female; | 2018 |
Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report.
Topics: Dapsone; Dermatitis; Drug Hypersensitivity; Female; Humans; Leprostatic Agents; Middle Aged; Sepsis; | 2019 |
Liver injury, rash, and encephalopathy in a 23-year-old Asian man prescribed dapsone.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Brain Diseases; Chemical and Drug Induced Liver Inju | 2019 |
Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Topics: Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Lepro | 2019 |
Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
Topics: Adult; China; Dapsone; Drug Hypersensitivity; Female; HLA-B Antigens; Humans; Leprostatic Agents; Le | 2013 |
Dapsone hypersensitivity syndrome among leprosy patients in China.
Topics: Adolescent; Adult; Aged; Child; China; Dapsone; Drug Hypersensitivity; Female; Humans; Incidence; Le | 2012 |
HLA-B*13:01 and the dapsone hypersensitivity syndrome.
Topics: Adult; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Genetic Predisposition to | 2013 |
Different roads, same destination.
Topics: Dapsone; Drug Hypersensitivity; Female; HLA-B Antigens; Humans; Leprostatic Agents; Leprosy; Male | 2014 |
Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: a case report.
Topics: Adult; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Hypersensitivity; Female; Humans | 2014 |
Dapsone hypersensitivity syndrome with myocarditis.
Topics: Adolescent; Dapsone; Drug Hypersensitivity; Female; Humans; Myocarditis | 2014 |
Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Exanthema; Female; Humans; Male; Purpu | 2015 |
Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Topics: Adult; Dapsone; Drug Hypersensitivity; Eosinophilia; Humans; Leprostatic Agents; Leprosy, Lepromatou | 2015 |
A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
Topics: Adult; Dapsone; Drug Hypersensitivity; Fatal Outcome; Female; Heart; Humans; Leprostatic Agents; Lep | 2016 |
A multiplex allele-specific real-time polymerase chain reaction assay for HLA-B*13:01 genotyping in four Chinese populations.
Topics: Alleles; Base Sequence; China; Dapsone; DNA Primers; DNA Probes; Drug Hypersensitivity; Ethnicity; E | 2016 |
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy; Dapsone; Drug Hypersensitivity; Drug Toleran | 2016 |
Leprosy: not always an easy diagnosis and often a management challenge.
Topics: Adult; Aged, 80 and over; Arm; Back; Clofazimine; Dapsone; Diagnosis, Differential; Drug Hypersensit | 2009 |
Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome.
Topics: Anti-Infective Agents; Atrioventricular Block; Dapsone; Drug Hypersensitivity; Female; Humans; Middl | 2009 |
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Chemical and Drug Induced Liver Injur | 2009 |
Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
Topics: Adult; Dapsone; Dengue; Diagnosis, Differential; Drug Hypersensitivity; Erythema; Female; Fever; His | 2010 |
Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?
Topics: Acne Vulgaris; Administration, Cutaneous; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Dr | 2010 |
Causes of death among active leprosy patients in China.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; China; Dapsone; Drug Hypers | 2011 |
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient.
Topics: Dapsone; Drug Hypersensitivity; Humans; Leprostatic Agents; Male; Methylprednisolone Hemisuccinate; | 2012 |
Dapsone syndrome--first Malaysian paediatric case report.
Topics: Anti-Infective Agents; Child; Dapsone; Drug Hypersensitivity; Early Diagnosis; Female; Humans; Syndr | 2012 |
French dapsone survey.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; France; Health Care Surveys; | 2002 |
[Dapsone-induced sensory peripheral neuropathy].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colorectal Neoplasms; Dapsone; Diagnosis, Differentia | 2003 |
Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Topics: Adult; Cholangitis; Dapsone; Drug Eruptions; Drug Hypersensitivity; Fever; Humans; Hyperbilirubinemi | 2003 |
A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Humans; Middle Aged | 2003 |
DESENSITIZATION FOR DAPSONE DERMATITIS.
Topics: Dapsone; Dermatitis; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Leprosy; Sulfones; | 1963 |
POLYSENSITIVITY TO ANTI-LEPROSY DRUGS.
Topics: Dapsone; Drug Eruptions; Drug Hypersensitivity; Drug Resistance; Drug Resistance, Microbial; Humans; | 1964 |
FIXED ERUPTION IN DEEPLY PIGMENTED SUBJECTS: CLINICAL OBSERVATIONS ON 350 PATIENTS.
Topics: Black People; Congo; Dapsone; Diagnosis; Drug Eruptions; Drug Hypersensitivity; Exanthema; Leprosy; | 1964 |
Cross-reactivity and sulfonamide antibiotics.
Topics: Anti-Infective Agents; Cross Reactions; Dapsone; Diuretics; Drug Hypersensitivity; Humans; Sulfonami | 2004 |
Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.
Topics: Adolescent; Adult; Antimalarials; Dapsone; Diagnosis, Differential; Drug Combinations; Drug Eruption | 2004 |
Dapsone hypersensitivity or viral exanthem?
Topics: Dapsone; Diagnosis, Differential; Drug Hypersensitivity; Exanthema; Humans; Immunization; Leprostati | 2004 |
Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Topics: Acute Kidney Injury; Adult; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; | 2005 |
Renal hypersensitivity vasculitis associated with dapsone.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Cyclophosphamide; Dapsone; Drug Hy | 2005 |
A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Cytomegalovirus; Dapsone; Desmoglein 1; Drug Hyp | 2006 |
Adverse reactions associated with dapsone therapy in HIV-positive patients: a case presentation and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; | 2006 |
The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation.
Topics: Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Dermatitis, Exfoliative; Drug Hy | 2006 |
Severe dapsone hypersensitivity syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Drug Eruptions; D | 2006 |
Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Diagnosis, Differen | 2006 |
Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Topics: Adolescent; Adult; Aged; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; | 2007 |
Side-effects of antileprosy drugs in common use.
Topics: Clofazimine; Dapsone; Drug Hypersensitivity; Ethionamide; Humans; Leprostatic Agents; Leprosy; Rifam | 1983 |
Dapsone hypersensitivity. The sulfone syndrome revisited.
Topics: Acne Vulgaris; Adolescent; Anemia, Hemolytic; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1981 |
Hypersensitivity reaction to dapsone: report from Malaysia.
Topics: Adolescent; Dapsone; Dermatitis Herpetiformis; Drug Hypersensitivity; Female; Humans; Leprosy; Malay | 1984 |
The dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Humans; Syndr | 1982 |
Dapsone syndrome.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Drug Hypersensitivi | 1995 |
Dapsone syndrome.
Topics: Adult; Dapsone; Drug Eruptions; Drug Hypersensitivity; Female; Fever; Humans; Liver; Syndrome | 1994 |
Hepatic injury in sulfone syndrome: hepatitis or cholestasis?
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Dapsone; Drug Hypersensiti | 1995 |
Sulfone syndrome in a patient receiving steroids for pemphigus.
Topics: Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Drug Therapy, Combinat | 1994 |
Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Dapsone; Drug | 1994 |
Dapsone syndrome in a Filipino man.
Topics: Adolescent; Dapsone; Drug Hypersensitivity; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; | 1995 |
Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Dapsone; Dose-Response Relationship, D | 1996 |
Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.
Topics: Adult; Aged; CD4 Lymphocyte Count; Dapsone; Drug Hypersensitivity; Erythrocytes; Glutathione; HIV In | 1996 |
Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; CD4 Lymphocyte Count; Clindamyci | 1996 |
The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis.
Topics: Adolescent; Dapsone; Dermatitis Herpetiformis; Dermatologic Agents; Drug Hypersensitivity; Female; H | 1997 |
Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases.
Topics: Adolescent; Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Eryt | 1998 |
Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
Topics: Adult; Dapsone; Drug Hypersensitivity; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male | 1998 |
Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Desensitization, Immun | 1998 |
Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Follow-Up Stu | 1999 |
Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
Topics: Adolescent; Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Incidence; India; Leprostatic Age | 2001 |
[An Antilles fever. Dapsone allergy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpet | 2001 |
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathi | 2002 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabi | 2002 |
Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
Topics: Adult; Antimalarials; Dapsone; Drug Combinations; Drug Hypersensitivity; Glucocorticoids; Humans; Ma | 2002 |
Abnormal cutaneous reactions in dermatitis herpetiformis.
Topics: Adult; Aged; Aspirin; Biopsy; Dapsone; Dermatitis Herpetiformis; Drug Hypersensitivity; Female; Huma | 1975 |
Sulfones and sulfonamides in dermatology today.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity; Hemolysis; Humans; Kidney Diseases; Methemoglobinem | 1979 |
[Dapsone syndrome].
Topics: Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Erythematosus, Cutaneous; Syndrome | 1991 |
Are dapsone hypersensitivity reactions dose related?
Topics: Child; Dapsone; Dose-Response Relationship, Drug; Drug Hypersensitivity; Humans; Leprosy; Male | 1990 |
[Hypersensitivity pneumonia caused by sulfonamides].
Topics: Cross Reactions; Dapsone; Dermatitis Herpetiformis; Drug Hypersensitivity; Humans; Male; Middle Aged | 1990 |
Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy.
Topics: Adolescent; Adult; Aged; Child; Cohort Studies; Dapsone; Drug Hypersensitivity; Drug Therapy, Combin | 1989 |
Hypersensitivity reaction to dapsone.
Topics: Adult; Dapsone; Dermatitis, Exfoliative; Drug Hypersensitivity; Humans; Leprosy; Male; Registries | 1986 |
Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Topics: Anemia, Hemolytic; Dapsone; Drug Hypersensitivity; Fever; Headache; Hepatitis; Humans; Male; Middle | 1988 |
Dapsone syndrome occurring in two brothers.
Topics: Adult; Dapsone; Drug Hypersensitivity; Humans; Leprosy; Male; Syndrome | 1986 |
Acute renal failure--a complication of new multidrug regimen for treatment of leprosy.
Topics: Acute Kidney Injury; Adult; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Lepro | 1986 |
Liver involvement in the sulfone syndrome.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Female; Fever; Humans; Liver | 1986 |
Hypersensitivity reaction to dapsone. Four case reports.
Topics: Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Male; Middle Aged | 1985 |
Antimalarial effects of sulphormethoxine, diaphenylsulphone and separate combinations of these with pyrimethamine: a review of preliminary investigations carried out in Tanzania.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Dapsone; Drug Hypersensitivity; Drug Resistanc | 1968 |